Tilray Brands, Inc. TLRY

When you say rescheduling won’t affect either

[Keeler]

Tilray OR the MSOs - do you not grasp that there are 6 MSO with annual sales exceeding $1 billion - compared to Tilrays $70 million f(or $280 million annually)reported last quarter?

Do you not Get that US MSOs regardless of federal legalization or rescheduling, already sell either medical or rec cannabis in 40 states? Those products include infused beverage sales?

If the US legalizes years from now - maybe Tilray will get some US sales, but it will be far more beneficial for US companies - in the meantime, US MSOs will continue to sell cannabis in the US - and Tilray won't 

 

Post by Vegas63on Dec 09, 2023 10:44am

48 Views 

Post# 35776195

Who cares about descheduling or safe

Yes Keeler you're right about descheduling  or safe not effecting  Tilray.,.,  Everyone knows this ,,
it's common knowledge,,,,

It also won't affect MSO companies in the United States because it  wil never get passed in the Senate,,,
It doesn't matter what version it is ,,,revised,, new and improved   ,, whatever version you want,,,